Global Pensions highlights focus on long-term value for pharmaceutical companies in Pharma Futures 2
From the article:
Institutional investors could increase their weightings in pharmaceutical firms if the industry examines a new study, according to Martin Eijgenhuijsen senior portfolio manager at ABP Investments.
Read more at Global Pensions (subscription required).
Filed under:
Press Inquiries
Want to know more about SustainAbility?
RECENT TWEETS
- Loading the 3 latest tweets...
